Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system

Objective: We re-classified patients with stage IB–II disease (based on the 2008 system) and compared the outcomes with those obtained after using the 2018 International Federation of Gynecology and Obstetrics (FIGO) staging system. Materials and methods: We reviewed the data of 154 patients with ce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daiken Osaku, Hiroaki Komatsu, Masayo Okawa, Yuki Iida, Shinya Sato, Tetsuro Oishi, Tasuku Harada
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/4160a0165ddd4010965f39ef2bd86ab8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4160a0165ddd4010965f39ef2bd86ab8
record_format dspace
spelling oai:doaj.org-article:4160a0165ddd4010965f39ef2bd86ab82021-11-18T04:44:44ZRe-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system1028-455910.1016/j.tjog.2021.09.016https://doaj.org/article/4160a0165ddd4010965f39ef2bd86ab82021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1028455921002564https://doaj.org/toc/1028-4559Objective: We re-classified patients with stage IB–II disease (based on the 2008 system) and compared the outcomes with those obtained after using the 2018 International Federation of Gynecology and Obstetrics (FIGO) staging system. Materials and methods: We reviewed the data of 154 patients with cervical cancer who underwent radical hysterectomy at our hospital during 2006–2016. Pathological, histological, and radiographic data were used to re-classify the cases based on the 2018 FIGO system. We compared these outcomes to those obtained after using the 2008 FIGO assignments. Overall survival (OS) was calculated from primary therapy initiation until death or the last follow-up examination. Results: The histological types were squamous cell carcinoma (108 cases) and others (46 cases). The 2008 FIGO system assignments were stage IB1, IB2, IIA1, IIA2, and IIB (87, 27, seven, five, and 28 patients, respectively). The new 2018 FIGO system assignments were stage IB1, IB2, IB3, IIA1, IIA2, IIB, and IIIC1 (52, 26, 16, six, three, 21, and 30 patients, respectively). Re-classification to stage IIIC1 disease was observed for previously assigned stage IB1, IB2, IIA1, IIA2, and IIB cases (10, seven, two, two, and nine cases, respectively). The median OS durations based on the 2018 FIGO system were 71.7, 61.1, and 62.3 months for patients with stage IB1, IB2, and IB3 (p = 0.04) disease, respectively. The new stage IB3/IIA2/IIB cases had longer OS than the old stage IB2/IIA2/IIB cases. A positive computed tomography (CT) finding of nodal involvement was observed in 37% of cases with pathological confirmation of pelvic lymph node (LN) involvement. Using CT to identify pelvic LN metastasis had a sensitivity of 37% and specificity of 93%. Conclusion: The 2018 FIGO staging system for cervical cancer after radical hysterectomy showed a better ability to differentiate survival outcomes. However, the image evaluation method should be reconsidered.Daiken OsakuHiroaki KomatsuMasayo OkawaYuki IidaShinya SatoTetsuro OishiTasuku HaradaElsevierarticleHysterectomyLymph nodesSquamous cell carcinomaUterine cervical cancerGynecology and obstetricsRG1-991ENTaiwanese Journal of Obstetrics & Gynecology, Vol 60, Iss 6, Pp 1054-1058 (2021)
institution DOAJ
collection DOAJ
language EN
topic Hysterectomy
Lymph nodes
Squamous cell carcinoma
Uterine cervical cancer
Gynecology and obstetrics
RG1-991
spellingShingle Hysterectomy
Lymph nodes
Squamous cell carcinoma
Uterine cervical cancer
Gynecology and obstetrics
RG1-991
Daiken Osaku
Hiroaki Komatsu
Masayo Okawa
Yuki Iida
Shinya Sato
Tetsuro Oishi
Tasuku Harada
Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system
description Objective: We re-classified patients with stage IB–II disease (based on the 2008 system) and compared the outcomes with those obtained after using the 2018 International Federation of Gynecology and Obstetrics (FIGO) staging system. Materials and methods: We reviewed the data of 154 patients with cervical cancer who underwent radical hysterectomy at our hospital during 2006–2016. Pathological, histological, and radiographic data were used to re-classify the cases based on the 2018 FIGO system. We compared these outcomes to those obtained after using the 2008 FIGO assignments. Overall survival (OS) was calculated from primary therapy initiation until death or the last follow-up examination. Results: The histological types were squamous cell carcinoma (108 cases) and others (46 cases). The 2008 FIGO system assignments were stage IB1, IB2, IIA1, IIA2, and IIB (87, 27, seven, five, and 28 patients, respectively). The new 2018 FIGO system assignments were stage IB1, IB2, IB3, IIA1, IIA2, IIB, and IIIC1 (52, 26, 16, six, three, 21, and 30 patients, respectively). Re-classification to stage IIIC1 disease was observed for previously assigned stage IB1, IB2, IIA1, IIA2, and IIB cases (10, seven, two, two, and nine cases, respectively). The median OS durations based on the 2018 FIGO system were 71.7, 61.1, and 62.3 months for patients with stage IB1, IB2, and IB3 (p = 0.04) disease, respectively. The new stage IB3/IIA2/IIB cases had longer OS than the old stage IB2/IIA2/IIB cases. A positive computed tomography (CT) finding of nodal involvement was observed in 37% of cases with pathological confirmation of pelvic lymph node (LN) involvement. Using CT to identify pelvic LN metastasis had a sensitivity of 37% and specificity of 93%. Conclusion: The 2018 FIGO staging system for cervical cancer after radical hysterectomy showed a better ability to differentiate survival outcomes. However, the image evaluation method should be reconsidered.
format article
author Daiken Osaku
Hiroaki Komatsu
Masayo Okawa
Yuki Iida
Shinya Sato
Tetsuro Oishi
Tasuku Harada
author_facet Daiken Osaku
Hiroaki Komatsu
Masayo Okawa
Yuki Iida
Shinya Sato
Tetsuro Oishi
Tasuku Harada
author_sort Daiken Osaku
title Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system
title_short Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system
title_full Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system
title_fullStr Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system
title_full_unstemmed Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system
title_sort re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 figo staging system
publisher Elsevier
publishDate 2021
url https://doaj.org/article/4160a0165ddd4010965f39ef2bd86ab8
work_keys_str_mv AT daikenosaku reclassificationofuterinecervicalcancercasestreatedwithradicalhysterectomybasedonthe2018figostagingsystem
AT hiroakikomatsu reclassificationofuterinecervicalcancercasestreatedwithradicalhysterectomybasedonthe2018figostagingsystem
AT masayookawa reclassificationofuterinecervicalcancercasestreatedwithradicalhysterectomybasedonthe2018figostagingsystem
AT yukiiida reclassificationofuterinecervicalcancercasestreatedwithradicalhysterectomybasedonthe2018figostagingsystem
AT shinyasato reclassificationofuterinecervicalcancercasestreatedwithradicalhysterectomybasedonthe2018figostagingsystem
AT tetsurooishi reclassificationofuterinecervicalcancercasestreatedwithradicalhysterectomybasedonthe2018figostagingsystem
AT tasukuharada reclassificationofuterinecervicalcancercasestreatedwithradicalhysterectomybasedonthe2018figostagingsystem
_version_ 1718425094331564032